company logo

Technical Program Manager in Mason, OH

Myriad Genetics, Inc

Mason, OH 45040
6w ago
Save

compensation:

$80K - $100K*

specialty:

Program Management

experience:

5 - 7 years

Job Description

We are currently looking for Technical Program Managers who want to work on innovative products that will help people make life-changing decisions. Utilize your technical and business skills to make meaningful impact in an industry that is desperate for innovation and change! This is a great opportunity to join an entrepreneurial, cross-functional team working on practical technical challenges and directly contributing to the commercial success of the company.

In the position of Technical Program Manager (Lab Operations) you will be responsible defining, prioritizing and implementing solutions to support Laboratory, Medical, and R&D operations.

This position is with the Neuroscience business unit located in Mason, Ohio.

Responsibilities

What you'll do:

  • Be the program manager for several in-house designed and built systems; LIMs (lab information management system) that powers our industry leading NGS (next-generation
See More

Valid through: 2020-3-4

About Myriad Genetics

Myriad Genetics, Inc. is an American molecular diagnostic company based in Salt Lake City, Utah, United States. Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease. This information is used to guide the development of new molecular diagnostic products that assess an individuals risk for developing disease later in life (predictive medicine), identify a patients likelihood of responding to a particular drug therapy (personalized medicine), assess a patients risk of disease progression and disease recurrence (personalized medicine), and measure disease activity. Myriads discovery of the breast cancer gene, BRCA1 was universally acclaimed as a monumental achievement: “There is no more exciting story in medical science.” Myriad was the subject of scrutiny after it became involved in a lawsuit over its patenting practices, which led to the landmark Supreme Court decision Association for Molecular Pathology v. Myriad Genetics. In August 2016 Myriad announced it would acquire Assurex Health for up to $410 million, expanding the companys genetic testing for psychotropic medicine selection. The global search for the genetic basis of breast and ovarian cancers began in earnest in 1988. In 1990, at an American Society of Human Genetics Meeting, a team of scientists led by Mary-Claire King, Ph.D., from University of California, Berkeley announced the localization through linkage analysis of a gene associated with increased risk for breast cancer (BRCA1) to the long arm of chromosome 17. In August 1994, Mark Skolnick and researchers at Myriad, along with colleagues at the University of Utah, the U.S National Institutes of Health (NIH), and McGill University sequenced BRCA1. In 2013, the actress Angelina Jolie had her ovaries removed because she tested positive for a mutation in the BRCA1 gene. This led to a surge in demand by women for genetic testing.
Total Jobs:
51
Total Experts:
5
Average Pay:
$114,312
Total value of jobs:
$9,145,000
% Masters:
36%

Myriad Genetics Photos

company social media photocompany social media photocompany social media photocompany social media photo
* Ladders Estimates